Dosimetry and Gastrointestinal Toxicity Relationships in a Phase II Trial of Pelvic Lymph Node Radiotherapy in Advanced Localised Prostate Cancer
Pelvic lymph node (PLN) radiotherapy for high-risk prostate cancer is limited by late gastrointestinal toxicity. Application of rectal and bowel constraints may reduce risks of side-effects. We evaluated associations between intensity-modulated radiotherapy (IMRT) dose-volume data and long-term gastrointestinal toxicity.
Source: Clinical Oncology - Category: Radiology Authors: M.R. Ferreira, K. Thomas, L. Truelove, A. Khan, C. Parker, D.P. Dearnaley, S. Gulliford Tags: Original Article Source Type: research
More News: Cancer | Cancer & Oncology | Gastroenterology | Intensity-Modulated Radiation Therapy | Prostate Cancer | Radiology | Toxicology